Further, CXCL4 levels were markedly elevated in plasma of patients with SSc and highly correlated with skin fibrosis, ILD, and PAH [85], suggesting the utility of this marker to predict the progression of the lung involvement in SSc. The gene discussed is PF4; the disease is systemic sclerosis.